Fenebrutinib HCl

Fenebrutinib HCl
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-TQ0242L-25mg 25 mg

7 - 10 business days*

1,440.00€
 
Description: Fenebrutinib is orally available inhibitor of Bruton's tyrosine kinase (BTK) with... more
Product information "Fenebrutinib HCl"
Description: Fenebrutinib is orally available inhibitor of Bruton's tyrosine kinase (BTK) with antineoplastic activity. Upon administration, GDC-0853 inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. This prevents both B-cell activation and BTK-mediated activation of downstream survival pathways, leading to the inhibition of the growth of malignant B-cells that overexpress BTK. Target: Others. Smiles: Cl.C[C@H]1CN(CCN1c1ccc(Nc2cc(cn(C)c2=O)-c2ccnc(N3CCn4c5CC(C)(C)Cc5cc4C3=O)c2CO)nc1)C1COC1
Keywords: GDC 0853, RG 7845, GDC-0853, GDC0853, RG7845, RG-7845
Supplier: TargetMol
Supplier-Nr: TQ0242L

Properties

MW: 701.27 D
Formula: C37H45ClN8O4

Database Information

CAS : 2128304-54-9| Matching products

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Fenebrutinib HCl"
Write a review
or to review a product.
Viewed